Clinical trial of cellular immunotherapy for malignant tumor (gamma-delta T cell-based cancer immunotherapy)
Not Applicable
- Conditions
- all classes of malignant tumors, after treatment with (or not applicable for) standard therapies for cancers
- Registration Number
- JPRN-UMIN000009422
- Lead Sponsor
- Center for Advanced Medical Innovation, Kyushu University
- Brief Summary
under analysis
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients to be excluded would satisfy any of the following conditions: (1) T cell- or NK cell-originated leukemia/lymphoma (2) serum positive for HTLV-1 and/or HIV antibody (3) organ- or allogeneic bone marrow-transplant recipients (4) Patients to be or wishing for pregnancy, or breast-feeding (5) Inward patients (6) Patientss who are regarded as inadequate for study enrollment by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method